u 74389f has been researched along with Arterial Occlusive Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kroupis, C; Lagiou, M; Papalois, A; Perlikos, F; Rizou, T; Toumpoulis, IK | 1 |
1 other study(ies) available for u 74389f and Arterial Occlusive Diseases
Article | Year |
---|---|
Lazaroid (U-74389G) ameliorates lung injury due to lipid peroxidation and nitric oxide synthase-dependent reactive oxygen species generation caused by remote systematic ischemia-reperfusion following thoracoabdominal aortic occlusion.
Topics: Animals; Antioxidants; Aorta, Thoracic; Arterial Occlusive Diseases; Disease Models, Animal; Lipid Peroxidation; Lung Injury; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pregnatrienes; Reactive Oxygen Species; Reperfusion Injury; Swine | 2018 |